| 3.4 |
24.0 |
GO:0018406 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 3.0 |
12.1 |
GO:1903445 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 1.9 |
5.7 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 1.8 |
5.4 |
GO:1903565 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 1.7 |
13.3 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 1.6 |
4.8 |
GO:0034414 |
tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) |
| 1.6 |
4.7 |
GO:0006174 |
dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 1.5 |
7.5 |
GO:0002386 |
immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 1.4 |
4.3 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 1.4 |
8.7 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 1.4 |
4.2 |
GO:0019520 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 1.4 |
4.2 |
GO:0031445 |
regulation of heterochromatin assembly(GO:0031445) positive regulation of heterochromatin assembly(GO:0031453) |
| 1.4 |
2.8 |
GO:1990180 |
mitochondrial tRNA 3'-end processing(GO:1990180) |
| 1.4 |
6.9 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 1.3 |
5.3 |
GO:1990166 |
protein localization to site of double-strand break(GO:1990166) |
| 1.3 |
10.2 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 1.2 |
1.2 |
GO:0072434 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 1.2 |
5.9 |
GO:1903904 |
negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
| 1.2 |
12.8 |
GO:0046104 |
thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 1.1 |
19.2 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 1.1 |
4.4 |
GO:1901895 |
negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 1.1 |
3.3 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 1.1 |
3.3 |
GO:0002101 |
tRNA wobble cytosine modification(GO:0002101) |
| 1.1 |
3.2 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 1.1 |
4.2 |
GO:2000314 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 1.0 |
2.1 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) |
| 1.0 |
3.1 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 1.0 |
66.5 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 1.0 |
4.0 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 1.0 |
1.0 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 1.0 |
1.9 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.9 |
0.9 |
GO:2000397 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.9 |
3.7 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.9 |
2.8 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.9 |
3.7 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.9 |
7.3 |
GO:2000232 |
regulation of rRNA processing(GO:2000232) |
| 0.9 |
13.6 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.9 |
7.1 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.9 |
16.9 |
GO:0042424 |
catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.9 |
7.1 |
GO:1990822 |
basic amino acid transmembrane transport(GO:1990822) |
| 0.9 |
6.1 |
GO:0035522 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.9 |
5.1 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.8 |
2.5 |
GO:0072312 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.8 |
28.3 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
| 0.8 |
5.8 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.8 |
2.5 |
GO:0006147 |
guanine catabolic process(GO:0006147) |
| 0.8 |
8.8 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.8 |
2.4 |
GO:2000078 |
positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.8 |
3.9 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.8 |
6.8 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 0.8 |
3.0 |
GO:1902530 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.7 |
24.0 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.7 |
14.9 |
GO:0033617 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) |
| 0.7 |
2.2 |
GO:0019303 |
D-ribose catabolic process(GO:0019303) |
| 0.7 |
25.0 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.7 |
2.2 |
GO:0035915 |
pore formation in membrane of other organism(GO:0035915) |
| 0.7 |
2.9 |
GO:0010430 |
fatty acid omega-oxidation(GO:0010430) |
| 0.7 |
4.3 |
GO:1903677 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.7 |
2.2 |
GO:0031393 |
negative regulation of prostaglandin biosynthetic process(GO:0031393) |
| 0.7 |
2.1 |
GO:0060152 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.7 |
12.7 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) |
| 0.7 |
3.5 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.7 |
2.1 |
GO:1904884 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.7 |
2.7 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.7 |
2.0 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.7 |
2.7 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.7 |
2.0 |
GO:0006393 |
termination of mitochondrial transcription(GO:0006393) |
| 0.7 |
3.9 |
GO:0071033 |
nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 0.6 |
0.6 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.6 |
2.6 |
GO:0034552 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.6 |
5.7 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.6 |
8.3 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.6 |
4.9 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.6 |
3.7 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.6 |
3.1 |
GO:1901090 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.6 |
1.8 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.6 |
14.4 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.6 |
3.0 |
GO:0001555 |
oocyte growth(GO:0001555) |
| 0.6 |
4.7 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.6 |
4.7 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.6 |
1.8 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.6 |
5.2 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.6 |
2.9 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.6 |
2.9 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.6 |
4.5 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.6 |
4.0 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.5 |
2.2 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.5 |
4.3 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.5 |
2.1 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.5 |
0.5 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.5 |
9.3 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.5 |
2.1 |
GO:0034628 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.5 |
1.5 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.5 |
2.0 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.5 |
6.9 |
GO:0070525 |
tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.5 |
3.5 |
GO:0032377 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.5 |
2.0 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.5 |
1.5 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.5 |
5.3 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.5 |
2.4 |
GO:1902998 |
regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.5 |
5.8 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.5 |
0.5 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.5 |
1.4 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.5 |
0.5 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.5 |
4.2 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.5 |
0.9 |
GO:0006740 |
NADPH regeneration(GO:0006740) |
| 0.5 |
1.4 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.5 |
3.2 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.5 |
1.4 |
GO:0019413 |
acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
| 0.4 |
9.0 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.4 |
4.0 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.4 |
3.5 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.4 |
1.3 |
GO:0071140 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.4 |
3.1 |
GO:0061709 |
reticulophagy(GO:0061709) |
| 0.4 |
3.0 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.4 |
0.4 |
GO:0018312 |
peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.4 |
6.5 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.4 |
1.7 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.4 |
10.2 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.4 |
1.3 |
GO:0061155 |
apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.4 |
1.7 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.4 |
0.4 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.4 |
0.4 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.4 |
1.2 |
GO:1905214 |
regulation of RNA binding(GO:1905214) |
| 0.4 |
1.2 |
GO:0046452 |
dihydrofolate metabolic process(GO:0046452) |
| 0.4 |
0.8 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.4 |
10.9 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.4 |
2.0 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.4 |
2.4 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.4 |
2.4 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.4 |
5.1 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.4 |
1.2 |
GO:0035048 |
splicing factor protein import into nucleus(GO:0035048) |
| 0.4 |
1.6 |
GO:0036369 |
transcription factor catabolic process(GO:0036369) |
| 0.4 |
0.4 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.4 |
1.1 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 0.4 |
0.8 |
GO:0071907 |
determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.4 |
1.5 |
GO:0070434 |
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.4 |
0.4 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.4 |
1.5 |
GO:0090156 |
cellular sphingolipid homeostasis(GO:0090156) |
| 0.4 |
6.0 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.4 |
3.0 |
GO:0060235 |
lens induction in camera-type eye(GO:0060235) |
| 0.4 |
4.0 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.4 |
7.2 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.4 |
2.2 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.4 |
0.4 |
GO:0010746 |
regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.4 |
1.1 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.4 |
2.5 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.4 |
1.4 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 0.4 |
0.7 |
GO:0051097 |
negative regulation of helicase activity(GO:0051097) |
| 0.3 |
1.4 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.3 |
8.7 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.3 |
1.7 |
GO:0072674 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.3 |
0.7 |
GO:0044407 |
biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.3 |
0.7 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.3 |
3.7 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
| 0.3 |
1.7 |
GO:1904764 |
negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.3 |
1.0 |
GO:0018160 |
peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 0.3 |
2.0 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.3 |
1.3 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.3 |
1.3 |
GO:0038098 |
sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.3 |
0.7 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.3 |
4.3 |
GO:0090240 |
positive regulation of histone H4 acetylation(GO:0090240) |
| 0.3 |
1.0 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.3 |
2.3 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.3 |
1.0 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.3 |
0.6 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 0.3 |
0.3 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.3 |
2.2 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.3 |
1.9 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.3 |
1.3 |
GO:0035261 |
external genitalia morphogenesis(GO:0035261) |
| 0.3 |
0.9 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.3 |
1.6 |
GO:0033387 |
putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.3 |
1.6 |
GO:0009698 |
phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
| 0.3 |
0.9 |
GO:0007225 |
patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
| 0.3 |
5.0 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.3 |
0.9 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.3 |
1.2 |
GO:0051311 |
meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
| 0.3 |
0.9 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.3 |
1.5 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.3 |
2.1 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.3 |
0.9 |
GO:1903892 |
negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
| 0.3 |
4.5 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.3 |
0.9 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 0.3 |
1.8 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.3 |
4.2 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.3 |
1.5 |
GO:1901679 |
nucleotide transmembrane transport(GO:1901679) |
| 0.3 |
0.9 |
GO:0097156 |
fasciculation of motor neuron axon(GO:0097156) |
| 0.3 |
3.2 |
GO:0014877 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.3 |
2.3 |
GO:0017062 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 0.3 |
1.2 |
GO:2000845 |
testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.3 |
4.9 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.3 |
2.0 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.3 |
3.4 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.3 |
0.9 |
GO:0060279 |
positive regulation of ovulation(GO:0060279) |
| 0.3 |
2.5 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
| 0.3 |
3.9 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.3 |
0.8 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.3 |
1.7 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.3 |
2.2 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.3 |
2.8 |
GO:0050428 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.3 |
1.9 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.3 |
1.1 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.3 |
1.1 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.3 |
2.4 |
GO:0006335 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.3 |
2.4 |
GO:0046075 |
dTTP metabolic process(GO:0046075) |
| 0.3 |
1.1 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.3 |
2.7 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.3 |
4.3 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.3 |
0.8 |
GO:1903371 |
regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.3 |
0.5 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.3 |
1.1 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) asymmetric Golgi ribbon formation(GO:0090164) |
| 0.3 |
1.1 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 0.3 |
0.8 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.3 |
2.4 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.3 |
0.3 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.3 |
1.0 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.3 |
0.8 |
GO:1903487 |
positive regulation of vascular wound healing(GO:0035470) regulation of lactation(GO:1903487) |
| 0.3 |
0.8 |
GO:0051793 |
medium-chain fatty acid catabolic process(GO:0051793) |
| 0.3 |
0.5 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.3 |
2.8 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 0.3 |
1.8 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.3 |
0.8 |
GO:0060661 |
submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.3 |
2.5 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.2 |
2.0 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.2 |
1.0 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.2 |
0.7 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.2 |
0.7 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.2 |
0.5 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.2 |
3.2 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.2 |
9.9 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.2 |
0.5 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
| 0.2 |
1.7 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.2 |
1.2 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.2 |
1.5 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.2 |
1.0 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 |
0.7 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.2 |
1.0 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.2 |
0.2 |
GO:1903891 |
regulation of ATF6-mediated unfolded protein response(GO:1903891) |
| 0.2 |
1.7 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.2 |
0.5 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.2 |
1.7 |
GO:0045007 |
depurination(GO:0045007) |
| 0.2 |
1.0 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.2 |
0.7 |
GO:2000706 |
amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 0.2 |
1.4 |
GO:0038016 |
insulin receptor internalization(GO:0038016) |
| 0.2 |
0.5 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.2 |
0.9 |
GO:0018283 |
metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.2 |
0.5 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.2 |
1.4 |
GO:0033152 |
immunoglobulin V(D)J recombination(GO:0033152) |
| 0.2 |
0.9 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.2 |
0.7 |
GO:1904204 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.2 |
0.2 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.2 |
1.8 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.2 |
0.7 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.2 |
3.2 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.2 |
1.6 |
GO:1902739 |
interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.2 |
2.3 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.2 |
0.7 |
GO:1902524 |
positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 0.2 |
0.2 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 |
1.4 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.2 |
0.7 |
GO:0034769 |
basement membrane disassembly(GO:0034769) |
| 0.2 |
3.1 |
GO:0031054 |
pre-miRNA processing(GO:0031054) |
| 0.2 |
1.1 |
GO:0097056 |
selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.2 |
3.3 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.2 |
2.9 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.2 |
1.3 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.2 |
0.7 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.2 |
0.2 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.2 |
0.7 |
GO:1903937 |
response to acrylamide(GO:1903937) |
| 0.2 |
7.9 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.2 |
1.5 |
GO:0046103 |
adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 0.2 |
2.6 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.2 |
0.7 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.2 |
1.1 |
GO:1903751 |
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.2 |
4.3 |
GO:0034205 |
beta-amyloid formation(GO:0034205) |
| 0.2 |
11.6 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.2 |
0.6 |
GO:0061341 |
non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 0.2 |
0.4 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.2 |
0.4 |
GO:0034093 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.2 |
0.6 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.2 |
5.8 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.2 |
0.6 |
GO:0070662 |
mast cell proliferation(GO:0070662) |
| 0.2 |
2.3 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 |
0.8 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.2 |
3.1 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.2 |
0.4 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.2 |
0.6 |
GO:0002856 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) negative regulation of interleukin-3 production(GO:0032712) negative regulation of granulocyte colony-stimulating factor production(GO:0071656) negative regulation of macrophage colony-stimulating factor production(GO:1901257) |
| 0.2 |
0.2 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.2 |
4.5 |
GO:0050655 |
dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.2 |
0.4 |
GO:0010044 |
response to aluminum ion(GO:0010044) |
| 0.2 |
0.6 |
GO:0002023 |
reduction of food intake in response to dietary excess(GO:0002023) |
| 0.2 |
0.6 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.2 |
14.3 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 |
5.0 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.2 |
1.2 |
GO:0070943 |
neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 0.2 |
2.4 |
GO:0070862 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 |
0.8 |
GO:0009304 |
tRNA transcription(GO:0009304) 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.2 |
0.8 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 |
2.0 |
GO:0071799 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.2 |
2.4 |
GO:0015781 |
pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.2 |
1.2 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.2 |
0.6 |
GO:1901355 |
response to rapamycin(GO:1901355) |
| 0.2 |
0.8 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.2 |
1.2 |
GO:0052422 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.2 |
1.0 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.2 |
4.0 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 |
1.1 |
GO:0060667 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) prostate epithelial cord elongation(GO:0060523) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 0.2 |
1.7 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 |
0.6 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 0.2 |
0.8 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.2 |
0.4 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.2 |
0.9 |
GO:0002357 |
defense response to tumor cell(GO:0002357) |
| 0.2 |
0.6 |
GO:0000451 |
rRNA 2'-O-methylation(GO:0000451) |
| 0.2 |
0.6 |
GO:1904017 |
cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.2 |
0.6 |
GO:1904579 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.2 |
0.9 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.2 |
2.2 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.2 |
37.1 |
GO:0060271 |
cilium morphogenesis(GO:0060271) |
| 0.2 |
0.5 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.2 |
0.9 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.2 |
0.9 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.2 |
2.2 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.2 |
0.5 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.2 |
0.7 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.2 |
0.9 |
GO:0046116 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.2 |
0.4 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.2 |
2.3 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.2 |
0.5 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.2 |
0.2 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 0.2 |
0.5 |
GO:0019464 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.2 |
2.7 |
GO:0042737 |
drug catabolic process(GO:0042737) |
| 0.2 |
0.2 |
GO:0051177 |
meiotic sister chromatid cohesion(GO:0051177) |
| 0.2 |
0.5 |
GO:0098937 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.2 |
1.1 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.2 |
0.2 |
GO:0032902 |
neurotrophin production(GO:0032898) nerve growth factor production(GO:0032902) |
| 0.2 |
1.4 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.2 |
1.2 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.2 |
0.9 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.2 |
0.3 |
GO:0097267 |
omega-hydroxylase P450 pathway(GO:0097267) |
| 0.2 |
0.9 |
GO:2000690 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.2 |
2.6 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 |
0.5 |
GO:0044537 |
regulation of circulating fibrinogen levels(GO:0044537) |
| 0.2 |
1.2 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.2 |
0.7 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 |
1.0 |
GO:0070294 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.2 |
0.3 |
GO:0098923 |
retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
| 0.2 |
1.8 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.2 |
0.7 |
GO:0098957 |
anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.2 |
1.0 |
GO:0006531 |
aspartate metabolic process(GO:0006531) |
| 0.2 |
0.3 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.2 |
1.8 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.2 |
0.5 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.2 |
1.1 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 0.2 |
2.3 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.2 |
0.6 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.2 |
1.1 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.2 |
0.5 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.2 |
0.8 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.2 |
2.2 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.2 |
0.3 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.2 |
0.5 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.2 |
1.1 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.2 |
0.5 |
GO:0061727 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.2 |
6.5 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.2 |
0.6 |
GO:0018032 |
protein amidation(GO:0018032) |
| 0.2 |
1.4 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.2 |
1.1 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.2 |
0.2 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.2 |
0.5 |
GO:0044725 |
chromatin reprogramming in the zygote(GO:0044725) |
| 0.1 |
0.3 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.1 |
0.6 |
GO:1904796 |
regulation of core promoter binding(GO:1904796) |
| 0.1 |
0.4 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 |
0.3 |
GO:0002032 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.1 |
0.4 |
GO:0034395 |
regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 0.1 |
2.1 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.1 |
0.9 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 |
0.1 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.1 |
7.2 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.1 |
1.2 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 |
10.4 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.1 |
0.6 |
GO:0015744 |
succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.1 |
1.6 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
1.7 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.1 |
0.1 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 0.1 |
0.3 |
GO:0033076 |
isoquinoline alkaloid metabolic process(GO:0033076) phytoalexin metabolic process(GO:0052314) |
| 0.1 |
3.7 |
GO:0042554 |
superoxide anion generation(GO:0042554) |
| 0.1 |
0.4 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.1 |
3.9 |
GO:0006978 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
| 0.1 |
0.4 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.1 |
1.1 |
GO:0003402 |
planar cell polarity pathway involved in axis elongation(GO:0003402) |
| 0.1 |
0.6 |
GO:0009635 |
response to herbicide(GO:0009635) |
| 0.1 |
0.4 |
GO:1900138 |
negative regulation of phospholipase A2 activity(GO:1900138) |
| 0.1 |
1.6 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.1 |
1.0 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.1 |
0.4 |
GO:0031550 |
positive regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031550) |
| 0.1 |
1.8 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 |
1.5 |
GO:0048302 |
isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
| 0.1 |
0.3 |
GO:0060809 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.1 |
0.5 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 0.1 |
2.4 |
GO:0047497 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.1 |
1.6 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.1 |
1.2 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.1 |
1.6 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.1 |
0.7 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.1 |
0.4 |
GO:0060931 |
sinoatrial node cell development(GO:0060931) |
| 0.1 |
1.8 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.1 |
2.6 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 |
0.4 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.1 |
1.4 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 0.1 |
0.6 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 |
0.5 |
GO:1904479 |
negative regulation of intestinal absorption(GO:1904479) |
| 0.1 |
0.6 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
1.0 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.1 |
0.9 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.1 |
0.5 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.1 |
1.7 |
GO:0003373 |
dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.1 |
0.5 |
GO:0032474 |
otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
| 0.1 |
0.9 |
GO:0008334 |
histone mRNA metabolic process(GO:0008334) |
| 0.1 |
3.0 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 |
0.4 |
GO:0061573 |
endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 0.1 |
0.5 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 |
1.4 |
GO:0045008 |
depyrimidination(GO:0045008) |
| 0.1 |
0.5 |
GO:0031118 |
rRNA pseudouridine synthesis(GO:0031118) |
| 0.1 |
0.4 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.1 |
0.1 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.1 |
1.2 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
0.4 |
GO:2000502 |
negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.1 |
0.1 |
GO:1905049 |
negative regulation of metallopeptidase activity(GO:1905049) |
| 0.1 |
0.7 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.6 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
1.8 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.1 |
0.2 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.1 |
1.1 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 |
0.8 |
GO:0035900 |
response to isolation stress(GO:0035900) |
| 0.1 |
1.3 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 |
1.0 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.1 |
0.6 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.1 |
0.4 |
GO:0060352 |
cell adhesion molecule production(GO:0060352) |
| 0.1 |
0.9 |
GO:2000373 |
regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.1 |
0.3 |
GO:0010956 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
| 0.1 |
3.0 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
1.3 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 |
0.9 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 |
0.9 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.1 |
0.2 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.1 |
0.4 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 |
0.7 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
1.1 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 0.1 |
0.9 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
5.1 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.1 |
0.3 |
GO:0060957 |
endocardial cell fate commitment(GO:0060957) endocardial cushion cell fate commitment(GO:0061445) positive regulation of determination of dorsal identity(GO:2000017) |
| 0.1 |
0.5 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.1 |
0.3 |
GO:0034034 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.1 |
0.2 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 |
0.2 |
GO:1904732 |
regulation of electron carrier activity(GO:1904732) |
| 0.1 |
6.6 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 |
0.9 |
GO:0048003 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.1 |
0.4 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.1 |
3.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.7 |
GO:2001200 |
positive regulation of dendritic cell differentiation(GO:2001200) |
| 0.1 |
1.6 |
GO:0006068 |
ethanol metabolic process(GO:0006067) ethanol catabolic process(GO:0006068) |
| 0.1 |
0.4 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.1 |
0.2 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.1 |
0.3 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.1 |
2.3 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.1 |
0.2 |
GO:0061312 |
BMP signaling pathway involved in heart development(GO:0061312) |
| 0.1 |
1.2 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.1 |
0.1 |
GO:0010536 |
positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.1 |
1.3 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.1 |
1.2 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.1 |
0.1 |
GO:0016074 |
snoRNA metabolic process(GO:0016074) |
| 0.1 |
1.5 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
0.4 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.1 |
5.8 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.1 |
0.4 |
GO:0034445 |
regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.1 |
1.1 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.1 |
0.3 |
GO:0051939 |
gamma-aminobutyric acid import(GO:0051939) |
| 0.1 |
1.2 |
GO:0006266 |
DNA ligation(GO:0006266) |
| 0.1 |
0.1 |
GO:1903576 |
response to L-arginine(GO:1903576) |
| 0.1 |
0.3 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.1 |
4.1 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.1 |
0.4 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.1 |
1.4 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.1 |
3.5 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 |
0.4 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 |
0.2 |
GO:0002442 |
serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.1 |
1.7 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.1 |
0.3 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.1 |
0.3 |
GO:2001034 |
positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.1 |
0.3 |
GO:0002501 |
peptide antigen assembly with MHC protein complex(GO:0002501) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.1 |
0.8 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.1 |
0.6 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
0.3 |
GO:0008615 |
pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 biosynthetic process(GO:0042819) |
| 0.1 |
2.3 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.1 |
0.6 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.5 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.1 |
0.4 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.1 |
0.4 |
GO:0003095 |
pressure natriuresis(GO:0003095) |
| 0.1 |
0.4 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.1 |
1.0 |
GO:0042354 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.1 |
1.6 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 |
0.7 |
GO:0072733 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 |
0.6 |
GO:0097052 |
L-kynurenine metabolic process(GO:0097052) |
| 0.1 |
0.7 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.1 |
1.0 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.1 |
0.4 |
GO:0055009 |
atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.1 |
2.2 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.1 |
0.2 |
GO:0003350 |
pulmonary myocardium development(GO:0003350) |
| 0.1 |
0.3 |
GO:0045917 |
positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.1 |
0.4 |
GO:0031635 |
adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) negative regulation of Wnt protein secretion(GO:0061358) |
| 0.1 |
0.2 |
GO:0010645 |
regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.1 |
0.7 |
GO:1904995 |
negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.1 |
0.8 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.1 |
0.2 |
GO:1905244 |
regulation of modification of synaptic structure(GO:1905244) |
| 0.1 |
1.1 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 |
3.1 |
GO:1900739 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.1 |
0.3 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.1 |
0.4 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.1 |
0.2 |
GO:0009631 |
cold acclimation(GO:0009631) |
| 0.1 |
1.9 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 |
0.2 |
GO:0061198 |
fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) fungiform papilla formation(GO:0061198) |
| 0.1 |
0.3 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.1 |
8.7 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.1 |
0.8 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.3 |
GO:0043321 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.1 |
0.3 |
GO:2000773 |
negative regulation of cellular senescence(GO:2000773) |
| 0.1 |
0.3 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.1 |
1.6 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.1 |
2.4 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
0.1 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.1 |
0.5 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.1 |
3.3 |
GO:0002381 |
immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
| 0.1 |
9.0 |
GO:0051439 |
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 0.1 |
1.6 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 |
0.2 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.1 |
0.2 |
GO:0009138 |
pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.1 |
0.7 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 |
0.2 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.1 |
2.7 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
2.0 |
GO:0010039 |
response to iron ion(GO:0010039) |
| 0.1 |
0.2 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.1 |
1.1 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
| 0.1 |
0.4 |
GO:0071073 |
positive regulation of phospholipid biosynthetic process(GO:0071073) |
| 0.1 |
0.7 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.5 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.1 |
1.0 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.3 |
GO:0042483 |
negative regulation of odontogenesis(GO:0042483) |
| 0.1 |
1.4 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
5.7 |
GO:0032729 |
positive regulation of interferon-gamma production(GO:0032729) |
| 0.1 |
0.5 |
GO:0043305 |
negative regulation of mast cell degranulation(GO:0043305) |
| 0.1 |
1.6 |
GO:0045739 |
positive regulation of DNA repair(GO:0045739) |
| 0.1 |
1.4 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.1 |
0.3 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.1 |
0.7 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.1 |
0.5 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.2 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
0.2 |
GO:0060526 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.1 |
1.0 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.1 |
0.5 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.1 |
0.4 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.1 |
1.0 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 |
0.2 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.1 |
0.4 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.8 |
GO:0043578 |
nuclear matrix organization(GO:0043578) |
| 0.1 |
0.2 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 0.1 |
0.4 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.1 |
0.4 |
GO:0032825 |
positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.1 |
0.2 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
0.5 |
GO:0000492 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
0.2 |
GO:1901143 |
insulin catabolic process(GO:1901143) |
| 0.1 |
0.2 |
GO:0045359 |
positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.1 |
0.3 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.1 |
2.8 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.4 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 0.1 |
0.4 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 |
0.1 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.1 |
0.4 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.1 |
0.3 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 |
1.0 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.1 |
0.7 |
GO:0015866 |
ADP transport(GO:0015866) |
| 0.1 |
0.9 |
GO:1990118 |
sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
0.3 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.1 |
0.3 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.1 |
1.4 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.1 |
1.3 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 |
0.2 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.1 |
0.5 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
0.7 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 |
2.0 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.1 |
1.4 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.1 |
0.5 |
GO:0000478 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.1 |
0.4 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.1 |
0.2 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.1 |
0.3 |
GO:2000984 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.1 |
0.1 |
GO:1904616 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.1 |
0.1 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
5.8 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.1 |
0.1 |
GO:0030974 |
thiamine pyrophosphate transport(GO:0030974) |
| 0.1 |
0.3 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 |
0.2 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
0.5 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.1 |
0.6 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 |
0.2 |
GO:0009085 |
lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
| 0.1 |
0.1 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
0.2 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.1 |
0.5 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.1 |
0.5 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 |
0.4 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.1 |
0.4 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.5 |
GO:2000645 |
negative regulation of receptor catabolic process(GO:2000645) |
| 0.1 |
0.1 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 |
0.2 |
GO:1990926 |
short-term synaptic potentiation(GO:1990926) |
| 0.1 |
0.1 |
GO:0033594 |
response to hydroxyisoflavone(GO:0033594) |
| 0.1 |
0.5 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
3.8 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.1 |
0.3 |
GO:2000503 |
regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.1 |
0.1 |
GO:0048867 |
stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
| 0.1 |
0.5 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.1 |
0.3 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 |
0.1 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.1 |
0.7 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.3 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.1 |
0.2 |
GO:0036111 |
very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.1 |
0.2 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.1 |
0.2 |
GO:1901159 |
glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.1 |
0.2 |
GO:1903382 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.1 |
0.3 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
0.4 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.2 |
GO:0035498 |
carnosine metabolic process(GO:0035498) |
| 0.1 |
0.1 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.1 |
0.2 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 |
1.4 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.1 |
0.3 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.1 |
0.3 |
GO:0009048 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 |
0.5 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 |
0.1 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 |
0.2 |
GO:0021650 |
vestibulocochlear nerve formation(GO:0021650) |
| 0.1 |
0.8 |
GO:0050427 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 |
0.7 |
GO:1904322 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 |
0.2 |
GO:0033685 |
negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.1 |
0.2 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
| 0.1 |
2.0 |
GO:0044819 |
mitotic G1 DNA damage checkpoint(GO:0031571) mitotic G1/S transition checkpoint(GO:0044819) |
| 0.0 |
1.0 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.2 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.0 |
0.2 |
GO:0006850 |
mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.0 |
0.9 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.0 |
1.1 |
GO:2001046 |
positive regulation of integrin-mediated signaling pathway(GO:2001046) |
| 0.0 |
0.7 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
1.0 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.0 |
0.6 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
0.4 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.1 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.0 |
0.1 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.0 |
0.4 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 |
0.8 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.4 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.0 |
1.1 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.3 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.0 |
0.1 |
GO:0061589 |
calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.0 |
0.5 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.3 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.0 |
0.3 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.3 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.0 |
0.7 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.0 |
0.1 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.0 |
0.6 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
1.3 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.0 |
0.1 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.0 |
0.2 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
| 0.0 |
0.4 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.4 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 |
0.1 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.0 |
1.8 |
GO:0008589 |
regulation of smoothened signaling pathway(GO:0008589) |
| 0.0 |
0.1 |
GO:1904021 |
negative regulation of G-protein coupled receptor internalization(GO:1904021) |
| 0.0 |
0.3 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.0 |
1.1 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.0 |
0.4 |
GO:0021853 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 |
0.3 |
GO:0034134 |
toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.0 |
0.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.9 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.0 |
0.0 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.0 |
0.5 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.6 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.1 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.0 |
0.1 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.0 |
0.2 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 0.0 |
0.1 |
GO:0071393 |
cellular response to progesterone stimulus(GO:0071393) |
| 0.0 |
0.2 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.0 |
0.2 |
GO:0010716 |
negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.0 |
0.1 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.0 |
0.1 |
GO:0033386 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.0 |
0.3 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.4 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.0 |
0.0 |
GO:1905071 |
occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.0 |
1.9 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.1 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
0.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.2 |
GO:1901163 |
trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
| 0.0 |
0.5 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.0 |
0.1 |
GO:0032237 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.0 |
0.3 |
GO:0042026 |
protein refolding(GO:0042026) |
| 0.0 |
0.9 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.0 |
GO:0097695 |
establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
| 0.0 |
0.6 |
GO:0035561 |
regulation of chromatin binding(GO:0035561) positive regulation of chromatin binding(GO:0035563) |
| 0.0 |
0.5 |
GO:0035358 |
regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
| 0.0 |
0.2 |
GO:0043372 |
positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) |
| 0.0 |
0.3 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.0 |
0.6 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.0 |
0.1 |
GO:0046878 |
positive regulation of saliva secretion(GO:0046878) |
| 0.0 |
0.4 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.0 |
0.1 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 |
0.2 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
| 0.0 |
0.2 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.0 |
0.5 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
0.1 |
GO:0032470 |
positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 0.0 |
0.2 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.0 |
0.2 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.0 |
0.2 |
GO:0015677 |
copper ion import(GO:0015677) |
| 0.0 |
0.1 |
GO:0034402 |
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.0 |
0.2 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.0 |
0.4 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.0 |
0.3 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.0 |
1.6 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
1.4 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 |
1.0 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.2 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.0 |
0.4 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.0 |
0.1 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.0 |
0.6 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.0 |
0.4 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
0.3 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.1 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.0 |
0.7 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.0 |
0.4 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 |
0.4 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.1 |
GO:0097698 |
base-excision repair, base-free sugar-phosphate removal(GO:0006286) telomere maintenance via base-excision repair(GO:0097698) |
| 0.0 |
1.3 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.0 |
0.3 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.0 |
0.0 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.0 |
0.1 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.0 |
0.2 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.0 |
0.3 |
GO:2000144 |
positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 |
0.2 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.0 |
0.1 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.0 |
0.1 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.0 |
0.6 |
GO:0036336 |
dendritic cell migration(GO:0036336) |
| 0.0 |
0.2 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.0 |
0.3 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.0 |
0.3 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.0 |
0.2 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.0 |
0.1 |
GO:0070092 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.0 |
0.1 |
GO:0040030 |
regulation of molecular function, epigenetic(GO:0040030) |
| 0.0 |
0.1 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 |
0.1 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.0 |
0.6 |
GO:0071305 |
cellular response to vitamin D(GO:0071305) |
| 0.0 |
0.2 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.0 |
0.1 |
GO:0045836 |
positive regulation of meiotic nuclear division(GO:0045836) |
| 0.0 |
0.0 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.0 |
0.1 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.0 |
0.5 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 |
0.3 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.1 |
GO:0014827 |
intestine smooth muscle contraction(GO:0014827) |
| 0.0 |
0.1 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.2 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 0.0 |
0.1 |
GO:0045212 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.0 |
0.3 |
GO:0035745 |
T-helper 2 cell cytokine production(GO:0035745) |
| 0.0 |
0.1 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.0 |
0.3 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.0 |
0.1 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.0 |
0.2 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.0 |
0.7 |
GO:0046622 |
positive regulation of organ growth(GO:0046622) |
| 0.0 |
0.2 |
GO:0036371 |
protein localization to T-tubule(GO:0036371) |
| 0.0 |
0.1 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.0 |
0.1 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.0 |
0.1 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.0 |
0.1 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.0 |
0.2 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.0 |
0.1 |
GO:1904779 |
regulation of protein localization to centrosome(GO:1904779) |
| 0.0 |
0.2 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.0 |
0.1 |
GO:0060770 |
epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.0 |
0.2 |
GO:0070193 |
synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
| 0.0 |
0.1 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.0 |
0.1 |
GO:1901529 |
positive regulation of anion channel activity(GO:1901529) positive regulation of anion transmembrane transport(GO:1903961) |
| 0.0 |
0.1 |
GO:2000143 |
negative regulation of DNA-templated transcription, initiation(GO:2000143) |
| 0.0 |
0.1 |
GO:0051121 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.0 |
0.2 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
1.3 |
GO:0043462 |
regulation of ATPase activity(GO:0043462) |
| 0.0 |
1.6 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.0 |
0.1 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.0 |
0.1 |
GO:0010578 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.0 |
0.3 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.1 |
GO:1900224 |
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.0 |
0.1 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.0 |
0.1 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.0 |
0.1 |
GO:0015870 |
acetylcholine transport(GO:0015870) |
| 0.0 |
0.2 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.0 |
0.1 |
GO:2000425 |
regulation of apoptotic cell clearance(GO:2000425) |
| 0.0 |
0.4 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.0 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.0 |
0.1 |
GO:1904683 |
regulation of metalloendopeptidase activity(GO:1904683) |
| 0.0 |
0.0 |
GO:0090310 |
negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.0 |
0.1 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.0 |
0.1 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 |
0.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.1 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 0.0 |
0.1 |
GO:0097195 |
pilomotor reflex(GO:0097195) positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.0 |
1.1 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.3 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 |
0.1 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.0 |
0.1 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.0 |
0.3 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.0 |
0.3 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
0.3 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 |
0.1 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.0 |
0.1 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.0 |
0.0 |
GO:0003157 |
endocardium development(GO:0003157) |
| 0.0 |
0.4 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 |
0.8 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
0.5 |
GO:0034724 |
DNA replication-independent nucleosome organization(GO:0034724) |
| 0.0 |
0.1 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.0 |
0.0 |
GO:0033158 |
regulation of protein import into nucleus, translocation(GO:0033158) |
| 0.0 |
0.1 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.0 |
0.1 |
GO:0042823 |
pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.0 |
0.3 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 |
0.1 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.0 |
0.1 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.0 |
0.1 |
GO:0006574 |
valine catabolic process(GO:0006574) |
| 0.0 |
0.2 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.0 |
0.1 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.0 |
0.1 |
GO:0071110 |
protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
| 0.0 |
6.0 |
GO:0048232 |
male gamete generation(GO:0048232) |
| 0.0 |
0.2 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.0 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.0 |
0.3 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 |
0.1 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.0 |
0.0 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.0 |
0.1 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.0 |
0.3 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.0 |
0.0 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.0 |
0.0 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 0.0 |
0.1 |
GO:0032291 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.0 |
0.1 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.1 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.0 |
0.0 |
GO:0034661 |
ncRNA catabolic process(GO:0034661) |
| 0.0 |
0.3 |
GO:0021952 |
central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.0 |
0.1 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.0 |
0.2 |
GO:0006853 |
carnitine shuttle(GO:0006853) |
| 0.0 |
0.4 |
GO:0021762 |
substantia nigra development(GO:0021762) |